A Phase 1, Placebo-controlled, Single-Ascending-Dose, Study of BIOPIN 6 in Healthy Adults

Conditions: Opioid Use Disorder Interventions: Combination Product: BIOPIN-6 Active Implant with Naltrexone; Device: BIOPIN-6 Placebo Implant Sponsors: Drug Delivery Company, LLC DBA Akyso Pharmaceuticals; National Institute on Drug Abuse (NIDA); Laboratory Corporation of America; Cognitive Research Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials